These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 15380044

  • 1. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C.
    Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
    [Abstract] [Full Text] [Related]

  • 2. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.
    Tengnér P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M.
    Arthritis Rheum; 1998 Dec; 41(12):2238-48. PubMed ID: 9870881
    [Abstract] [Full Text] [Related]

  • 3. Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells.
    Katsiougiannis S, Tenta R, Skopouli FN.
    Clin Exp Immunol; 2015 Aug; 181(2):244-52. PubMed ID: 25845745
    [Abstract] [Full Text] [Related]

  • 4. The association between autoantibody types and salivary gland hypofunction in patients with primary Sjögren's syndrome.
    Kim BE, Kwon JS, Choi JH, Park PG, Ahn HJ.
    J Oral Pathol Med; 2023 Feb; 52(2):188-194. PubMed ID: 36183157
    [Abstract] [Full Text] [Related]

  • 5. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.
    Kang KY, Kim HO, Kwok SK, Ju JH, Park KS, Sun DI, Jhun JY, Oh HJ, Park SH, Kim HY.
    Arthritis Res Ther; 2011 Feb; 13(5):R179. PubMed ID: 22030011
    [Abstract] [Full Text] [Related]

  • 6. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C.
    Arthritis Rheum; 2005 Jun; 52(6):1773-84. PubMed ID: 15934082
    [Abstract] [Full Text] [Related]

  • 7. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.
    Gerli R, Muscat C, Giansanti M, Danieli MG, Sciuto M, Gabrielli A, Fiandra E, Vitali C.
    Br J Rheumatol; 1997 Sep; 36(9):969-75. PubMed ID: 9376993
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, Lafeber FP, van Roon JA.
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [Abstract] [Full Text] [Related]

  • 9. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
    Skarstein K, Aqrawi LA, Øijordsbakken G, Jonsson R, Jensen JL.
    Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
    [Abstract] [Full Text] [Related]

  • 10. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.
    Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmström P, Wahren-Herlenius M, Jonsson R.
    Arthritis Rheum; 2003 Nov; 48(11):3187-201. PubMed ID: 14613282
    [Abstract] [Full Text] [Related]

  • 11. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D, Coleby R, Pontarini E, Prediletto E, Rivellese F, Hill DG, Derrac Soria A, Jones SA, Humphreys IR, Sutcliffe N, Tappuni AR, Pitzalis C, Jones GW, Bombardieri M.
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [Abstract] [Full Text] [Related]

  • 12. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
    Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, Patsouris E, Moutsopoulos HM.
    Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
    [Abstract] [Full Text] [Related]

  • 13. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S, Mostafa S, Rowan VS, Azzarolo AM.
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [Abstract] [Full Text] [Related]

  • 14. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R, Nyhagen C, Tabery H, Theander E.
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [Abstract] [Full Text] [Related]

  • 15. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome.
    Bombardieri M, Barone F, Humby F, Kelly S, McGurk M, Morgan P, Challacombe S, De Vita S, Valesini G, Spencer J, Pitzalis C.
    J Immunol; 2007 Oct 01; 179(7):4929-38. PubMed ID: 17878393
    [Abstract] [Full Text] [Related]

  • 16. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome.
    Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K.
    J Clin Immunol; 2005 May 01; 25(3):189-201. PubMed ID: 15981083
    [Abstract] [Full Text] [Related]

  • 17. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.
    Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S.
    J Immunol; 2008 Aug 15; 181(4):2898-906. PubMed ID: 18684981
    [Abstract] [Full Text] [Related]

  • 18. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
    Ciccia F, Alessandro R, Rodolico V, Guggino G, Raimondo S, Guarnotta C, Giardina A, Sireci G, Campisi G, De Leo G, Triolo G.
    Rheumatology (Oxford); 2013 Jun 15; 52(6):1009-17. PubMed ID: 23392590
    [Abstract] [Full Text] [Related]

  • 19. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome.
    Croia C, Astorri E, Murray-Brown W, Willis A, Brokstad KA, Sutcliffe N, Piper K, Jonsson R, Tappuni AR, Pitzalis C, Bombardieri M.
    Arthritis Rheumatol; 2014 Sep 15; 66(9):2545-57. PubMed ID: 24891330
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.
    Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA.
    Arthritis Rheum; 2009 Dec 15; 60(12):3633-41. PubMed ID: 19950301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.